95 related articles for article (PubMed ID: 10868303)
1. [Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment].
Mikasa K
Jpn J Antibiot; 2000 Apr; 53(4):253-60. PubMed ID: 10868303
[No Abstract] [Full Text] [Related]
2. [Administration of clarithromycin (CAM) to non-small cell lung cancer].
Majima T; Mikasa K; Sakamoto M; Hamada K; Konishi M; Maeda K; Yoshimoto E; Murakawa K; Takahashi K; Kita E; Narita N
Jpn J Antibiot; 2000 Jan; 53 Suppl A():52-5. PubMed ID: 10756452
[No Abstract] [Full Text] [Related]
3. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer].
Sakamoto M; Mikasa K; Sawaki M; Hamada K; Teramoto S; Ueta K; Majima T; Konishi M; Maeda K; Tsujimoto M; Mori K; Kita E; Narita N
Jpn J Antibiot; 1998 Jan; 51 Suppl A():50-2. PubMed ID: 9597485
[No Abstract] [Full Text] [Related]
5. [Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer].
Mikasa K; Sawaki M; Kita E; Hamada K; Sakamoto M; Konishi M; Maeda K; Teramoto S; Tsujimoto M; Mori K; Ueda K; Fukuoka K; Segawa K; Kataoka T; Narita N
Jpn J Antibiot; 1997 Mar; 50 Suppl A():45-8. PubMed ID: 9597439
[No Abstract] [Full Text] [Related]
6. [Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period].
Sakamoto M; Mikasa K; Majima T; Konishi M; Maeda K; Yoshimoto E; Murakawa K; Takahashi K; Kita E; Narita N
Jpn J Antibiot; 2000 Jan; 53 Suppl A():56-9. PubMed ID: 10756453
[No Abstract] [Full Text] [Related]
7. [Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
Mikasa K; Sawaki M; Kita E; Hamada K; Sakamoto M; Teramoto S; Narita N
Nihon Naika Gakkai Zasshi; 1997 Jan; 86(1):100-7. PubMed ID: 9102408
[No Abstract] [Full Text] [Related]
8. [Effect of kanglaite injection combined with Chinese drug therapy according to syndrome differentiation on quality of life and immune function in patients with advanced lung cancer].
Qin ZF; Wei PK; Li J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Aug; 22(8):618-9. PubMed ID: 12572387
[No Abstract] [Full Text] [Related]
9. [Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration].
Teramoto S; Kita E; Mikasa K; Hamada K; Konishi M; Maeda K; Sakamoto M; Tsujimoto M; Mori K; Sawaki M; Narita N
Jpn J Antibiot; 1997 Mar; 50 Suppl A():42-4. PubMed ID: 9597438
[No Abstract] [Full Text] [Related]
10. [Clinical application of the new action of macrolide preparations to respiratory diseases].
Mikasa K; Furunishi M; Maeda K; Sakamoto M; Ueta K; Mashima T; Kita E; Narita N
Nihon Naika Gakkai Zasshi; 1999 Aug; 88(8):1533-40. PubMed ID: 10475020
[No Abstract] [Full Text] [Related]
11. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
Ieshiro R; Goto G; Ota T; Yuasa K; Iguchi M; Okamura J
Jpn J Antibiot; 1997 Mar; 50 Suppl A():49-52. PubMed ID: 9597440
[No Abstract] [Full Text] [Related]
12. [Efficacy of clarithromycin on cancer cachexia in patients with primary non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Teramoto S; Konishi M; Maeda K; Tsujimoto M; Mori K; Sawaki M; Kita E; Narita N
Jpn J Antibiot; 1997 Mar; 50 Suppl A():38-41. PubMed ID: 9597437
[No Abstract] [Full Text] [Related]
13. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer--the second report].
Ieshiro R; Goto G; Ota T; Yuasa K; Iguchi M; Okamura J
Jpn J Antibiot; 1998 Jan; 51 Suppl A():47-9. PubMed ID: 9597484
[No Abstract] [Full Text] [Related]
14. Diminished natural killer-cell activity of interstitial pulmonary cell populations from patients with carcinoma of the lung.
deShazo RD; Moulder PV; Bozelka B; Chapman Y
Chest; 1987 Jan; 91(1):26-8. PubMed ID: 3792080
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells].
Hamada K; Sakamoto M; Mikasa K; Teramoto M; Mori K; Tsujimoto M; Maeda K; Konishi M; Sawaki M; Narita N; Kita E
Jpn J Antibiot; 1997 Mar; 50 Suppl A():28-31. PubMed ID: 9597434
[No Abstract] [Full Text] [Related]
16. [Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system].
Yano S; Sone S; Yamagishi T; Akashi T
Jpn J Antibiot; 1998 Jan; 51 Suppl A():72-4. PubMed ID: 9597491
[No Abstract] [Full Text] [Related]
17. [Effects of clarithromycin on experimental pulmonary metastasis].
Kokubo Y; Shibuya M; Hino M; Azuma A; Aoyama S; Matsuda K; Shu D; Kudo S
Jpn J Antibiot; 1997 Mar; 50 Suppl A():35-7. PubMed ID: 9597436
[No Abstract] [Full Text] [Related]
18. [Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer].
Teramoto S; Kita E; Mikasa K; Hamada K; Konishi M; Maeda K; Sakamoto M; Tsujimoto M; Mori K; Sawaki M; Narita N
Jpn J Antibiot; 1998 Jan; 51 Suppl A():53-5. PubMed ID: 9597486
[No Abstract] [Full Text] [Related]
19. [Effect of yifei kangliu yin on lung cancer metastasis and immune function].
Xu L; Liu JX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Jul; 17(7):401-3. PubMed ID: 10322858
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of immunomodulators in multimodal treatment of patients with lung cancer].
Vagner VP; Voĭtkevich EG; Zakora GI; Chirvina ED
Klin Med (Mosk); 1991 Dec; 69(12):55-9. PubMed ID: 1787682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
